Global Migraine Headache Drugs Market Size, Status and Forecast 2021-2027

片頭痛治療薬の世界市場規模・現状・予測2021年-2027年

◆タイトル:Global Migraine Headache Drugs Market Size, Status and Forecast 2021-2027
◆商品コード:QY21APR3786
◆調査・発行会社:QYResearch
◆発行日:2021年4月
◆ページ数:132
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、主要地域
◆産業分野:医薬品、ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥444,600見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥666,900見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥889,200見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearchの日本における正規販売代理店です。

【レポートの概要】

本調査資料では、片頭痛治療薬の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(アルモトリプタン、エレトリプタン、スマトリプタン、リザトリプタン、ゾルミトリプタン、ナラトリプタン、フロバトリプタン、その他)、用途別市場規模(急性片頭痛、一般片頭痛、古典的片頭痛、慢性片頭痛、その他片頭痛)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・片頭痛治療薬の市場動向
・企業の競争状況、市場シェア
・片頭痛治療薬の種類別市場規模(アルモトリプタン、エレトリプタン、スマトリプタン、リザトリプタン、ゾルミトリプタン、ナラトリプタン、フロバトリプタン、その他)
・片頭痛治療薬の用途別市場規模(急性片頭痛、一般片頭痛、古典的片頭痛、慢性片頭痛、その他片頭痛)
・片頭痛治療薬の北米市場規模2016-2027(アメリカ、カナダ)
・片頭痛治療薬の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・片頭痛治療薬のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・片頭痛治療薬の中南米市場規模2016-2027(メキシコ、ブラジル)
・片頭痛治療薬の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Pfizer、Novartis、Johnson & Johnson、GSK、Merck、Eli Lilly、Teva、AstraZeneca、Sun Pharma、Grunenthal、Endo Pharmaceuticals、Mylan、Bayer、Amneal Pharmaceuticals、Apotex、Ajanta Pharma、Allergan)
・結論

Migraine treatment usually is with over-the-counter (OTC) migraine medication or prescription drugs.
Migraines, this type of headache often involves only one side of the head, but in some cases, patients may have pain bilaterally or on both sides. Migraine headache is a result of specific changes within the brain. It causes severe head pain that is often accompanied by sensitivity to light, sound, or smells.

Market Analysis and Insights: Global Migraine Headache Drugs Market
The global Migraine Headache Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Migraine Headache Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Migraine Headache Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Migraine Headache Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Migraine Headache Drugs market.

Global Migraine Headache Drugs Scope and Market Size
Migraine Headache Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Migraine Headache Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Almotriptan
Eletriptan
Sumatriptan
Rizatriptan
Zolmitriptan
Naratriptan
Frovatriptan
Others

Segment by Application
Acute Migraine
Common Migraine
Classic Migraine
Chronic Migraine
Other Migraines

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
Novartis
Johnson & Johnson
GSK
Merck
Eli Lilly
Teva
AstraZeneca
Sun Pharma
Grunenthal
Endo Pharmaceuticals
Mylan
Bayer
Amneal Pharmaceuticals
Apotex

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Migraine Headache Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Almotriptan
1.2.3 Eletriptan
1.2.4 Sumatriptan
1.2.5 Rizatriptan
1.2.6 Zolmitriptan
1.2.7 Naratriptan
1.2.8 Frovatriptan
1.2.9 Others
1.3 Market by Application
1.3.1 Global Migraine Headache Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Acute Migraine
1.3.3 Common Migraine
1.3.4 Classic Migraine
1.3.5 Chronic Migraine
1.3.6 Other Migraines
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Migraine Headache Drugs Market Perspective (2016-2027)
2.2 Migraine Headache Drugs Growth Trends by Regions
2.2.1 Migraine Headache Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Migraine Headache Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Migraine Headache Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Migraine Headache Drugs Industry Dynamic
2.3.1 Migraine Headache Drugs Market Trends
2.3.2 Migraine Headache Drugs Market Drivers
2.3.3 Migraine Headache Drugs Market Challenges
2.3.4 Migraine Headache Drugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Migraine Headache Drugs Players by Revenue
3.1.1 Global Top Migraine Headache Drugs Players by Revenue (2016-2021)
3.1.2 Global Migraine Headache Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Migraine Headache Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Migraine Headache Drugs Revenue
3.4 Global Migraine Headache Drugs Market Concentration Ratio
3.4.1 Global Migraine Headache Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Migraine Headache Drugs Revenue in 2020
3.5 Migraine Headache Drugs Key Players Head office and Area Served
3.6 Key Players Migraine Headache Drugs Product Solution and Service
3.7 Date of Enter into Migraine Headache Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Migraine Headache Drugs Breakdown Data by Type
4.1 Global Migraine Headache Drugs Historic Market Size by Type (2016-2021)
4.2 Global Migraine Headache Drugs Forecasted Market Size by Type (2022-2027)

5 Migraine Headache Drugs Breakdown Data by Application
5.1 Global Migraine Headache Drugs Historic Market Size by Application (2016-2021)
5.2 Global Migraine Headache Drugs Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Migraine Headache Drugs Market Size (2016-2027)
6.2 North America Migraine Headache Drugs Market Size by Type
6.2.1 North America Migraine Headache Drugs Market Size by Type (2016-2021)
6.2.2 North America Migraine Headache Drugs Market Size by Type (2022-2027)
6.2.3 North America Migraine Headache Drugs Market Size by Type (2016-2027)
6.3 North America Migraine Headache Drugs Market Size by Application
6.3.1 North America Migraine Headache Drugs Market Size by Application (2016-2021)
6.3.2 North America Migraine Headache Drugs Market Size by Application (2022-2027)
6.3.3 North America Migraine Headache Drugs Market Size by Application (2016-2027)
6.4 North America Migraine Headache Drugs Market Size by Country
6.4.1 North America Migraine Headache Drugs Market Size by Country (2016-2021)
6.4.2 North America Migraine Headache Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Migraine Headache Drugs Market Size (2016-2027)
7.2 Europe Migraine Headache Drugs Market Size by Type
7.2.1 Europe Migraine Headache Drugs Market Size by Type (2016-2021)
7.2.2 Europe Migraine Headache Drugs Market Size by Type (2022-2027)
7.2.3 Europe Migraine Headache Drugs Market Size by Type (2016-2027)
7.3 Europe Migraine Headache Drugs Market Size by Application
7.3.1 Europe Migraine Headache Drugs Market Size by Application (2016-2021)
7.3.2 Europe Migraine Headache Drugs Market Size by Application (2022-2027)
7.3.3 Europe Migraine Headache Drugs Market Size by Application (2016-2027)
7.4 Europe Migraine Headache Drugs Market Size by Country
7.4.1 Europe Migraine Headache Drugs Market Size by Country (2016-2021)
7.4.2 Europe Migraine Headache Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Migraine Headache Drugs Market Size (2016-2027)
8.2 Asia-Pacific Migraine Headache Drugs Market Size by Type
8.2.1 Asia-Pacific Migraine Headache Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Migraine Headache Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Migraine Headache Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Migraine Headache Drugs Market Size by Application
8.3.1 Asia-Pacific Migraine Headache Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Migraine Headache Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Migraine Headache Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Migraine Headache Drugs Market Size by Region
8.4.1 Asia-Pacific Migraine Headache Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Migraine Headache Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Migraine Headache Drugs Market Size (2016-2027)
9.2 Latin America Migraine Headache Drugs Market Size by Type
9.2.1 Latin America Migraine Headache Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Migraine Headache Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Migraine Headache Drugs Market Size by Type (2016-2027)
9.3 Latin America Migraine Headache Drugs Market Size by Application
9.3.1 Latin America Migraine Headache Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Migraine Headache Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Migraine Headache Drugs Market Size by Application (2016-2027)
9.4 Latin America Migraine Headache Drugs Market Size by Country
9.4.1 Latin America Migraine Headache Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Migraine Headache Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Migraine Headache Drugs Market Size (2016-2027)
10.2 Middle East & Africa Migraine Headache Drugs Market Size by Type
10.2.1 Middle East & Africa Migraine Headache Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Migraine Headache Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Migraine Headache Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Migraine Headache Drugs Market Size by Application
10.3.1 Middle East & Africa Migraine Headache Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Migraine Headache Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Migraine Headache Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Migraine Headache Drugs Market Size by Country
10.4.1 Middle East & Africa Migraine Headache Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Migraine Headache Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Migraine Headache Drugs Introduction
11.1.4 Pfizer Revenue in Migraine Headache Drugs Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Migraine Headache Drugs Introduction
11.2.4 Novartis Revenue in Migraine Headache Drugs Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Migraine Headache Drugs Introduction
11.3.4 Johnson & Johnson Revenue in Migraine Headache Drugs Business (2016-2021)
11.3.5 Johnson & Johnson Recent Development
11.4 GSK
11.4.1 GSK Company Details
11.4.2 GSK Business Overview
11.4.3 GSK Migraine Headache Drugs Introduction
11.4.4 GSK Revenue in Migraine Headache Drugs Business (2016-2021)
11.4.5 GSK Recent Development
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Migraine Headache Drugs Introduction
11.5.4 Merck Revenue in Migraine Headache Drugs Business (2016-2021)
11.5.5 Merck Recent Development
11.6 Eli Lilly
11.6.1 Eli Lilly Company Details
11.6.2 Eli Lilly Business Overview
11.6.3 Eli Lilly Migraine Headache Drugs Introduction
11.6.4 Eli Lilly Revenue in Migraine Headache Drugs Business (2016-2021)
11.6.5 Eli Lilly Recent Development
11.7 Teva
11.7.1 Teva Company Details
11.7.2 Teva Business Overview
11.7.3 Teva Migraine Headache Drugs Introduction
11.7.4 Teva Revenue in Migraine Headache Drugs Business (2016-2021)
11.7.5 Teva Recent Development
11.8 AstraZeneca
11.8.1 AstraZeneca Company Details
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Migraine Headache Drugs Introduction
11.8.4 AstraZeneca Revenue in Migraine Headache Drugs Business (2016-2021)
11.8.5 AstraZeneca Recent Development
11.9 Sun Pharma
11.9.1 Sun Pharma Company Details
11.9.2 Sun Pharma Business Overview
11.9.3 Sun Pharma Migraine Headache Drugs Introduction
11.9.4 Sun Pharma Revenue in Migraine Headache Drugs Business (2016-2021)
11.9.5 Sun Pharma Recent Development
11.10 Grunenthal
11.10.1 Grunenthal Company Details
11.10.2 Grunenthal Business Overview
11.10.3 Grunenthal Migraine Headache Drugs Introduction
11.10.4 Grunenthal Revenue in Migraine Headache Drugs Business (2016-2021)
11.10.5 Grunenthal Recent Development
11.11 Endo Pharmaceuticals
11.11.1 Endo Pharmaceuticals Company Details
11.11.2 Endo Pharmaceuticals Business Overview
11.11.3 Endo Pharmaceuticals Migraine Headache Drugs Introduction
11.11.4 Endo Pharmaceuticals Revenue in Migraine Headache Drugs Business (2016-2021)
11.11.5 Endo Pharmaceuticals Recent Development
11.12 Mylan
11.12.1 Mylan Company Details
11.12.2 Mylan Business Overview
11.12.3 Mylan Migraine Headache Drugs Introduction
11.12.4 Mylan Revenue in Migraine Headache Drugs Business (2016-2021)
11.12.5 Mylan Recent Development
11.13 Bayer
11.13.1 Bayer Company Details
11.13.2 Bayer Business Overview
11.13.3 Bayer Migraine Headache Drugs Introduction
11.13.4 Bayer Revenue in Migraine Headache Drugs Business (2016-2021)
11.13.5 Bayer Recent Development
11.14 Amneal Pharmaceuticals
11.14.1 Amneal Pharmaceuticals Company Details
11.14.2 Amneal Pharmaceuticals Business Overview
11.14.3 Amneal Pharmaceuticals Migraine Headache Drugs Introduction
11.14.4 Amneal Pharmaceuticals Revenue in Migraine Headache Drugs Business (2016-2021)
11.14.5 Amneal Pharmaceuticals Recent Development
11.15 Apotex
11.15.1 Apotex Company Details
11.15.2 Apotex Business Overview
11.15.3 Apotex Migraine Headache Drugs Introduction
11.15.4 Apotex Revenue in Migraine Headache Drugs Business (2016-2021)
11.15.5 Apotex Recent Development
11.16 Ajanta Pharma
11.16.1 Ajanta Pharma Company Details
11.16.2 Ajanta Pharma Business Overview
11.16.3 Ajanta Pharma Migraine Headache Drugs Introduction
11.16.4 Ajanta Pharma Revenue in Migraine Headache Drugs Business (2016-2021)
11.16.5 Ajanta Pharma Recent Development
11.17 Allergan
11.17.1 Allergan Company Details
11.17.2 Allergan Business Overview
11.17.3 Allergan Migraine Headache Drugs Introduction
11.17.4 Allergan Revenue in Migraine Headache Drugs Business (2016-2021)
11.17.5 Allergan Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Migraine Headache Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Almotriptan
Table 3. Key Players of Eletriptan
Table 4. Key Players of Sumatriptan
Table 5. Key Players of Rizatriptan
Table 6. Key Players of Zolmitriptan
Table 7. Key Players of Naratriptan
Table 8. Key Players of Frovatriptan
Table 9. Key Players of Others
Table 10. Global Migraine Headache Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Migraine Headache Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 12. Global Migraine Headache Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 13. Global Migraine Headache Drugs Market Share by Regions (2016-2021)
Table 14. Global Migraine Headache Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 15. Global Migraine Headache Drugs Market Share by Regions (2022-2027)
Table 16. Migraine Headache Drugs Market Trends
Table 17. Migraine Headache Drugs Market Drivers
Table 18. Migraine Headache Drugs Market Challenges
Table 19. Migraine Headache Drugs Market Restraints
Table 20. Global Migraine Headache Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 21. Global Migraine Headache Drugs Market Share by Players (2016-2021)
Table 22. Global Top Migraine Headache Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Migraine Headache Drugs as of 2020)
Table 23. Ranking of Global Top Migraine Headache Drugs Companies by Revenue (US$ Million) in 2020
Table 24. Global 5 Largest Players Market Share by Migraine Headache Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Migraine Headache Drugs Product Solution and Service
Table 27. Date of Enter into Migraine Headache Drugs Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Migraine Headache Drugs Market Size by Type (2016-2021) (US$ Million)
Table 30. Global Migraine Headache Drugs Revenue Market Share by Type (2016-2021)
Table 31. Global Migraine Headache Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 32. Global Migraine Headache Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 33. Global Migraine Headache Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 34. Global Migraine Headache Drugs Revenue Market Share by Application (2016-2021)
Table 35. Global Migraine Headache Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 36. Global Migraine Headache Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 37. North America Migraine Headache Drugs Market Size by Type (2016-2021) (US$ Million)
Table 38. North America Migraine Headache Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 39. North America Migraine Headache Drugs Market Size by Application (2016-2021) (US$ Million)
Table 40. North America Migraine Headache Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 41. North America Migraine Headache Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 42. North America Migraine Headache Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 43. Europe Migraine Headache Drugs Market Size by Type (2016-2021) (US$ Million)
Table 44. Europe Migraine Headache Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 45. Europe Migraine Headache Drugs Market Size by Application (2016-2021) (US$ Million)
Table 46. Europe Migraine Headache Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 47. Europe Migraine Headache Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 48. Europe Migraine Headache Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Migraine Headache Drugs Market Size by Type (2016-2021) (US$ Million)
Table 50. Asia-Pacific Migraine Headache Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Migraine Headache Drugs Market Size by Application (2016-2021) (US$ Million)
Table 52. Asia-Pacific Migraine Headache Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 53. Asia-Pacific Migraine Headache Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 54. Asia-Pacific Migraine Headache Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 55. Latin America Migraine Headache Drugs Market Size by Type (2016-2021) (US$ Million)
Table 56. Latin America Migraine Headache Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 57. Latin America Migraine Headache Drugs Market Size by Application (2016-2021) (US$ Million)
Table 58. Latin America Migraine Headache Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 59. Latin America Migraine Headache Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 60. Latin America Migraine Headache Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Migraine Headache Drugs Market Size by Type (2016-2021) (US$ Million)
Table 62. Middle East & Africa Migraine Headache Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Migraine Headache Drugs Market Size by Application (2016-2021) (US$ Million)
Table 64. Middle East & Africa Migraine Headache Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 65. Middle East & Africa Migraine Headache Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 66. Middle East & Africa Migraine Headache Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 67. Pfizer Company Details
Table 68. Pfizer Business Overview
Table 69. Pfizer Migraine Headache Drugs Product
Table 70. Pfizer Revenue in Migraine Headache Drugs Business (2016-2021) & (US$ Million)
Table 71. Pfizer Recent Development
Table 72. Novartis Company Details
Table 73. Novartis Business Overview
Table 74. Novartis Migraine Headache Drugs Product
Table 75. Novartis Revenue in Migraine Headache Drugs Business (2016-2021) & (US$ Million)
Table 76. Novartis Recent Development
Table 77. Johnson & Johnson Company Details
Table 78. Johnson & Johnson Business Overview
Table 79. Johnson & Johnson Migraine Headache Drugs Product
Table 80. Johnson & Johnson Revenue in Migraine Headache Drugs Business (2016-2021) & (US$ Million)
Table 81. Johnson & Johnson Recent Development
Table 82. GSK Company Details
Table 83. GSK Business Overview
Table 84. GSK Migraine Headache Drugs Product
Table 85. GSK Revenue in Migraine Headache Drugs Business (2016-2021) & (US$ Million)
Table 86. GSK Recent Development
Table 87. Merck Company Details
Table 88. Merck Business Overview
Table 89. Merck Migraine Headache Drugs Product
Table 90. Merck Revenue in Migraine Headache Drugs Business (2016-2021) & (US$ Million)
Table 91. Merck Recent Development
Table 92. Eli Lilly Company Details
Table 93. Eli Lilly Business Overview
Table 94. Eli Lilly Migraine Headache Drugs Product
Table 95. Eli Lilly Revenue in Migraine Headache Drugs Business (2016-2021) & (US$ Million)
Table 96. Eli Lilly Recent Development
Table 97. Teva Company Details
Table 98. Teva Business Overview
Table 99. Teva Migraine Headache Drugs Product
Table 100. Teva Revenue in Migraine Headache Drugs Business (2016-2021) & (US$ Million)
Table 101. Teva Recent Development
Table 102. AstraZeneca Company Details
Table 103. AstraZeneca Business Overview
Table 104. AstraZeneca Revenue in Migraine Headache Drugs Business (2016-2021) & (US$ Million)
Table 105. AstraZeneca Recent Development
Table 106. Sun Pharma Company Details
Table 107. Sun Pharma Business Overview
Table 108. Sun Pharma Migraine Headache Drugs Product
Table 109. Sun Pharma Revenue in Migraine Headache Drugs Business (2016-2021) & (US$ Million)
Table 110. Sun Pharma Recent Development
Table 111. Grunenthal Company Details
Table 112. Grunenthal Business Overview
Table 113. Grunenthal Migraine Headache Drugs Product
Table 114. Grunenthal Revenue in Migraine Headache Drugs Business (2016-2021) & (US$ Million)
Table 115. Grunenthal Recent Development
Table 116. Endo Pharmaceuticals Company Details
Table 117. Endo Pharmaceuticals Business Overview
Table 118. Endo Pharmaceuticals Migraine Headache Drugs Product
Table 119. Endo Pharmaceuticals Revenue in Migraine Headache Drugs Business (2016-2021) & (US$ Million)
Table 120. Endo Pharmaceuticals Recent Development
Table 121. Mylan Company Details
Table 122. Mylan Business Overview
Table 123. Mylan Migraine Headache Drugs Product
Table 124. Mylan Revenue in Migraine Headache Drugs Business (2016-2021) & (US$ Million)
Table 125. Mylan Recent Development
Table 126. Bayer Company Details
Table 127. Bayer Business Overview
Table 128. Bayer Migraine Headache Drugs Product
Table 129. Bayer Revenue in Migraine Headache Drugs Business (2016-2021) & (US$ Million)
Table 130. Bayer Recent Development
Table 131. Amneal Pharmaceuticals Company Details
Table 132. Amneal Pharmaceuticals Business Overview
Table 133. Amneal Pharmaceuticals Migraine Headache Drugs Product
Table 134. Amneal Pharmaceuticals Revenue in Migraine Headache Drugs Business (2016-2021) & (US$ Million)
Table 135. Amneal Pharmaceuticals Recent Development
Table 136. Apotex Company Details
Table 137. Apotex Business Overview
Table 138. Apotex Migraine Headache Drugs Product
Table 139. Apotex Revenue in Migraine Headache Drugs Business (2016-2021) & (US$ Million)
Table 140. Apotex Recent Development
Table 141. Ajanta Pharma Company Details
Table 142. Ajanta Pharma Business Overview
Table 143. Ajanta Pharma Migraine Headache Drugs Product
Table 144. Ajanta Pharma Revenue in Migraine Headache Drugs Business (2016-2021) & (US$ Million)
Table 145. Ajanta Pharma Recent Development
Table 146. Allergan Company Details
Table 147. Allergan Business Overview
Table 148. Allergan Migraine Headache Drugs Product
Table 149. Allergan Revenue in Migraine Headache Drugs Business (2016-2021) & (US$ Million)
Table 150. Allergan Recent Development
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Migraine Headache Drugs Market Share by Type: 2020 VS 2027
Figure 2. Almotriptan Features
Figure 3. Eletriptan Features
Figure 4. Sumatriptan Features
Figure 5. Rizatriptan Features
Figure 6. Zolmitriptan Features
Figure 7. Naratriptan Features
Figure 8. Frovatriptan Features
Figure 9. Others Features
Figure 10. Global Migraine Headache Drugs Market Share by Application: 2020 VS 2027
Figure 11. Acute Migraine Case Studies
Figure 12. Common Migraine Case Studies
Figure 13. Classic Migraine Case Studies
Figure 14. Chronic Migraine Case Studies
Figure 15. Other Migraines Case Studies
Figure 16. Migraine Headache Drugs Report Years Considered
Figure 17. Global Migraine Headache Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 18. Global Migraine Headache Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 19. Global Migraine Headache Drugs Market Share by Regions: 2020 VS 2027
Figure 20. Global Migraine Headache Drugs Market Share by Regions (2022-2027)
Figure 21. Global Migraine Headache Drugs Market Share by Players in 2020
Figure 22. Global Top Migraine Headache Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Migraine Headache Drugs as of 2020
Figure 23. The Top 10 and 5 Players Market Share by Migraine Headache Drugs Revenue in 2020
Figure 24. Global Migraine Headache Drugs Revenue Market Share by Type (2016-2021)
Figure 25. Global Migraine Headache Drugs Revenue Market Share by Type (2022-2027)
Figure 26. North America Migraine Headache Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. North America Migraine Headache Drugs Market Share by Type (2016-2027)
Figure 28. North America Migraine Headache Drugs Market Share by Application (2016-2027)
Figure 29. North America Migraine Headache Drugs Market Share by Country (2016-2027)
Figure 30. United States Migraine Headache Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Canada Migraine Headache Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Europe Migraine Headache Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Europe Migraine Headache Drugs Market Share by Type (2016-2027)
Figure 34. Europe Migraine Headache Drugs Market Share by Application (2016-2027)
Figure 35. Europe Migraine Headache Drugs Market Share by Country (2016-2027)
Figure 36. Germany Migraine Headache Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. France Migraine Headache Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. U.K. Migraine Headache Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Italy Migraine Headache Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Russia Migraine Headache Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Nordic Migraine Headache Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Asia-Pacific Migraine Headache Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Asia-Pacific Migraine Headache Drugs Market Share by Type (2016-2027)
Figure 44. Asia-Pacific Migraine Headache Drugs Market Share by Application (2016-2027)
Figure 45. Asia-Pacific Migraine Headache Drugs Market Share by Region (2016-2027)
Figure 46. China Migraine Headache Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Japan Migraine Headache Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. South Korea Migraine Headache Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Southeast Asia Migraine Headache Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. India Migraine Headache Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Australia Migraine Headache Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Latin America Migraine Headache Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Latin America Migraine Headache Drugs Market Share by Type (2016-2027)
Figure 54. Latin America Migraine Headache Drugs Market Share by Application (2016-2027)
Figure 55. Latin America Migraine Headache Drugs Market Share by Country (2016-2027)
Figure 56. Mexico Migraine Headache Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Brazil Migraine Headache Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Middle East & Africa Migraine Headache Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Middle East & Africa Migraine Headache Drugs Market Share by Type (2016-2027)
Figure 60. Middle East & Africa Migraine Headache Drugs Market Share by Application (2016-2027)
Figure 61. Middle East & Africa Migraine Headache Drugs Market Share by Country (2016-2027)
Figure 62. Turkey Migraine Headache Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Saudi Arabia Migraine Headache Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. UAE Migraine Headache Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 65. Pfizer Revenue Growth Rate in Migraine Headache Drugs Business (2016-2021)
Figure 66. Novartis Revenue Growth Rate in Migraine Headache Drugs Business (2016-2021)
Figure 67. Johnson & Johnson Revenue Growth Rate in Migraine Headache Drugs Business (2016-2021)
Figure 68. GSK Revenue Growth Rate in Migraine Headache Drugs Business (2016-2021)
Figure 69. Merck Revenue Growth Rate in Migraine Headache Drugs Business (2016-2021)
Figure 70. Eli Lilly Revenue Growth Rate in Migraine Headache Drugs Business (2016-2021)
Figure 71. Teva Revenue Growth Rate in Migraine Headache Drugs Business (2016-2021)
Figure 72. AstraZeneca Revenue Growth Rate in Migraine Headache Drugs Business (2016-2021)
Figure 73. Sun Pharma Revenue Growth Rate in Migraine Headache Drugs Business (2016-2021)
Figure 74. Grunenthal Revenue Growth Rate in Migraine Headache Drugs Business (2016-2021)
Figure 75. Endo Pharmaceuticals Revenue Growth Rate in Migraine Headache Drugs Business (2016-2021)
Figure 76. Mylan Revenue Growth Rate in Migraine Headache Drugs Business (2016-2021)
Figure 77. Bayer Revenue Growth Rate in Migraine Headache Drugs Business (2016-2021)
Figure 78. Amneal Pharmaceuticals Revenue Growth Rate in Migraine Headache Drugs Business (2016-2021)
Figure 79. Apotex Revenue Growth Rate in Migraine Headache Drugs Business (2016-2021)
Figure 80. Ajanta Pharma Revenue Growth Rate in Migraine Headache Drugs Business (2016-2021)
Figure 81. Allergan Revenue Growth Rate in Migraine Headache Drugs Business (2016-2021)
Figure 82. Bottom-up and Top-down Approaches for This Report
Figure 83. Data Triangulation
Figure 84. Key Executives Interviewed


【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[片頭痛治療薬の世界市場規模・現状・予測2021年-2027年] (Global Migraine Headache Drugs Market Size, Status and Forecast 2021-2027 / QY21APR3786)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆